NASDAQ : CVRX

CVRx, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 1.425 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 37.96M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

CVRx, Inc. (CVRX) reported revenue of 61.19M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue61.19M56.65M51.29M39.30M22.47M13.04M
Cost of Revenue8.01M8.31M8.33M6.26M5.00M3.64M
Gross Profit53.18M48.34M42.96M33.04M17.47M9.40M
Selling, General & Admin89.46M88.47M91.32M64.51M50.05M27.86M
Research & Development12.36M11.13M11.13M11.63M9.95M7.50M
Operating Expenses101.82M99.61M102.45M76.14M60.00M35.36M
Operating Income-48.64M-51.27M-59.49M-43.10M-42.53M-25.97M
Interest Expense-6.03M-5.83M-4.40M-1.80M-165.00K-2.22M
Other Non Operating Income (Expenses)2.69M3.77M3.98M3.85M1.37M-13.47M
EBT Excluding Unusual Items-51.97M-53.32M-59.91M-41.05M-41.32M-41.66M
Other Unusual Items-1.32M
Pretax Income-51.97M-53.32M-59.91M-41.05M-41.32M-42.99M
Income Tax Expense-6.00K-18.00K55.00K147.00K109.00K91.00K
Net Income-51.97M-53.31M-59.97M-41.20M-41.43M-43.08M
Net Income to Common-51.97M-53.31M-59.97M-41.20M-41.43M-43.08M
Shares Outstanding (Basic)26.32M26.08M22.60M20.75M20.53M10.36M
Shares Outstanding (Diluted)26.32M26.08M22.60M20.75M20.53M10.36M
EPS (Basic)-1.97-2.04-2.65-1.99-2.02-4.16
EPS (Diluted)-1.97-2.04-2.65-1.99-2.02-4.16
Free Cash Flow-41.05M-40.75M-40.51M-39.61M-43.36M-28.91M
Free Cash Flow Per Share-1.56-1.56-1.79-1.91-2.11-2.79
Gross Margin86.92%85.33%83.75%84.08%77.75%72.08%
Operating Margin-79.49%-90.49%-115.98%-109.69%-189.27%-199.20%
Profit Margin-84.93%-94.09%-116.91%-104.85%-184.38%-330.45%
Free Cash Flow Margin-67.09%-71.93%-78.97%-100.81%-192.99%-221.81%
EBITDA-47.84M-50.51M-58.87M-42.58M-42.12M-25.80M
EBITDA Margin-78.19%-89.16%-114.78%-108.36%-187.44%-197.91%
D&A For EBITDA793.00K756.00K619.00K522.00K412.00K168.00K
EBIT-48.64M-51.27M-59.49M-43.10M-42.53M-25.97M
EBIT Margin-79.49%-90.49%-115.98%-109.69%-189.27%-199.20%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents64.59M75.71M105.93M90.57M106.19M142.07M
Cash & Short-Term Investments64.59M75.71M105.93M90.57M106.19M142.07M
Receivables9.40M10.66M9.27M7.55M5.50M2.56M
Inventory13.03M12.21M12.11M10.98M6.96M3.88M
Prepaid Expenses2.47M3.07M2.50M2.99M4.22M2.58M
Total Current Assets89.49M101.65M129.81M112.09M122.88M151.10M
Property, Plant & Equipment2.77M3.12M3.57M3.11M2.03M1.43M
Other Long-Term Assets26.00K26.00K27.00K27.00K27.00K26.00K
Total Assets92.28M104.79M133.41M115.23M124.94M152.55M
Accounts Payable3.87M3.83M2.58M1.88M1.72M510.00K
Accrued Expenses6.83M9.04M7.76M5.62M6.03M5.05M
Current Portion of Leases371.00K352.00K282.00K231.00K222.00K
Current Income Taxes Payable53.00K93.00K135.00K125.00K120.00K351.00K
Total Current Liabilities11.12M13.32M10.76M7.86M8.09M5.91M
Long-Term Debt58.57M49.51M49.27M29.22M6.75M
Long-Term Leases448.00K638.00K877.00K1.16M117.00K
Other Long-Term Liabilities2.19M2.00M1.45M1.04M805.00K681.00K
Total Liabilities72.33M65.47M62.36M39.28M15.76M6.59M
Common Stock266.00K263.00K253.00K209.00K207.00K204.00K
Additional Paid-In Capital637.71M629.92M608.35M553.33M545.36M540.71M
Retained Earnings-617.82M-590.65M-537.35M-477.38M-436.18M-394.75M
Comprehensive Income & Other-204.00K-203.00K-206.00K-207.00K-207.00K-198.00K
Total Common Equity19.95M39.32M71.06M75.95M109.18M145.96M
Shareholders' Equity19.95M39.32M71.06M75.95M109.18M145.96M
Total Liabilities & Equity92.28M104.79M133.41M115.23M124.94M152.55M
Total Debt59.39M50.50M50.43M30.61M7.09M
Net Cash (Debt)5.20M25.20M55.50M59.96M99.11M142.07M
Net Cash Per Share0.200.972.462.894.8313.71
Filing Date Shares Outstanding26.64M26.31M26.04M20.93M20.69M20.48M
Total Common Shares Outstanding26.64M26.31M25.32M20.88M20.63M20.40M
Working Capital78.36M88.33M119.05M104.23M114.79M145.19M
Book Value Per Share0.751.492.813.645.297.16
Tangible Book Value19.95M39.32M71.06M75.95M109.18M145.96M
Tangible Book Value Per Share0.751.492.813.645.297.16
Machinery4.10M5.24M4.65M3.90M3.65M2.39M
Construction In Progress428.00K325.00K720.00K554.00K231.00K813.00K
Leasehold Improvements827.00K827.00K542.00K98.00K95.00K88.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-51.97M-53.31M-59.97M-41.20M-41.43M-43.08M
Depreciation & Amortization793.00K756.00K619.00K522.00K412.00K168.00K
Other Amortization289.00K241.00K203.00K154.00K25.00K229.00K
Loss (Gain) From Sale of Assets87.00K86.00K4.00K
Stock-Based Compensation12.26M11.05M19.05M6.30M3.89M1.91M
Other Operating Activities14.62M
Change in Accounts Receivable-2.25M-1.40M-1.72M-2.05M-2.94M-1.28M
Change in Inventory-1.31M-98.00K-1.12M-4.03M-3.08M-537.00K
Change in Accounts Payable842.00K1.25M698.00K165.00K1.21M27.00K
Change in Other Net Operating Assets794.00K1.25M3.09M1.10M-761.00K207.00K
Operating Cash Flow-40.46M-40.17M-39.14M-39.02M-42.68M-27.73M
Capital Expenditures-597.00K-580.00K-1.36M-591.00K-685.00K-1.18M
Investing Cash Flow-597.00K-580.00K-1.36M-591.00K-685.00K-1.18M
Long-Term Debt Issued20.00M22.50M7.50M
Long-Term Debt Repaid-21.30M
Net Debt Issued (Repaid)10.00M20.00M22.50M7.50M-21.30M
Issuance of Common Stock1.73M10.52M36.02M1.66M771.00K133.18M
Other Financing Activities-1.11M-152.00K-179.00K-778.00K-1.00K
Financing Cash Flow10.62M10.52M55.87M23.98M7.49M111.88M
Foreign Exchange Rate Adjustments-1.00K5.00K-1.00K3.00K-9.00K-8.00K
Net Cash Flow-30.44M-30.23M15.36M-15.62M-35.88M82.96M
Free Cash Flow-41.05M-40.75M-40.51M-39.61M-43.36M-28.91M
Free Cash Flow Margin-67.09%-71.93%-78.97%-100.81%-192.99%-221.81%
Free Cash Flow Per Share-1.56-1.56-1.79-1.91-2.11-2.79
Levered Free Cash Flow-23.80M-23.79M-20.93M-26.75M-28.74M-22.36M
Unlevered Free Cash Flow-20.32M-20.39M-18.39M-25.78M-28.67M-21.20M
Cash Interest Paid5.22M5.04M3.61M1.40M59.00K1.71M
Cash Income Tax Paid4.00K5.00K2.00K
Change in Working Capital-1.92M1.00M949.00K-4.80M-5.57M-1.58M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization36.23M186.09M307.42M654.44M377.72M248.90M
Enterprise Value31.04M151.49M257.70M586.83M268.13M97.47M
Last Close Price1.417.1012.6731.4418.3512.23
PS Ratio0.613.295.9916.6616.8119.09
PB Ratio1.884.734.338.623.461.71
P/TBV Ratio1.884.734.338.623.461.71
EV/Sales Ratio0.532.675.0214.9311.937.48
Debt / Equity Ratio2.981.280.710.400.07
Net Debt / Equity Ratio-0.26-0.64-0.78-0.79-0.91-0.97
Net Debt / EBITDA Ratio0.110.500.941.412.355.51
Net Debt / FCF Ratio0.130.621.371.512.294.91
Asset Turnover0.580.480.410.330.160.12
Inventory Turnover0.650.680.720.700.921.01
Quick Ratio6.656.4910.7012.4813.8124.48
Current Ratio8.047.6312.0614.2515.1925.57
Return on Equity (ROE)-133.44%-96.59%-81.58%-44.51%-32.48%-47.16%
Return on Assets (ROA)-28.70%-26.90%-29.91%-22.43%-19.16%-14.94%
Return on Capital Employed (ROCE)-59.90%-56.00%-48.50%-40.10%-36.40%-17.70%
Earnings Yield-145.21%-28.64%-19.51%-6.30%-10.97%-17.31%
FCF Yield-109.29%-21.90%-13.18%-6.05%-11.48%-11.62%
Buyback Yield / Dilution-5.82%-15.44%-8.88%-1.08%-98.19%-2,576.44%